Vivos Therapeutics (VVOS) EBITDA Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -257.00 |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | -92.00 |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 135.00 |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 1,339.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 4,229.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,229.00 |
| Mar 31, 2026 | 174.00 |
| Dec 31, 2025 | -2,622.00 |
| Sep 30, 2025 | 5,874.00 |
| Jun 30, 2025 | 4,216.00 |
| Mar 31, 2025 | 5,343.00 |
| Dec 31, 2024 | 9,321.00 |
| Sep 30, 2024 | 5,292.00 |
| Jun 30, 2024 | 4,322.00 |
| Mar 31, 2024 | -1,190.00 |
| Dec 31, 2023 | 6,828.00 |
| Sep 30, 2023 | -5,696.00 |
| Jun 30, 2023 | -8,910.00 |
| Mar 31, 2023 | -4,695.00 |